CUE logo

Cue Biopharma (CUE) Company Overview

Profile

Full Name:

Cue Biopharma, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 2, 2018

Indexes:

Not included

Description:

Cue Biopharma Inc is a biopharmaceutical company working in the clinical stage. It is developing a new patented class of biological drugs for selective modulation of the human immune system to treat a wide range of cancers and autoimmune diseases. Its lead drug candidate includes CUE-101, a variant form of interleukin-2 cytokine and T-cell antigen for targeting and activating cancer-specific T cells associated with HPV-related cancer. Other products in development include CUE-102, CUE-103, CUE-400, and CUE-401. Cue Biopharma, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.

Events Calendar

Earnings

Next earnings date:

Apr 8, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Apr 8, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Aug 20, 24 Stifel
Buy
Jul 26, 24 Piper Sandler
Overweight
Jul 26, 24 JMP Securities
Market Outperform
Apr 9, 24 Stifel
Buy
Apr 9, 24 Oppenheimer
Outperform
Apr 3, 24 Piper Sandler
Overweight
Mar 13, 24 Jefferies
Buy
Nov 6, 23 Piper Sandler
Overweight
Jun 15, 23 Stifel
Buy
May 15, 23 JMP Securities
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Cue Biopharma?
  • Does Cue Biopharma pay dividends?
  • What sector is Cue Biopharma in?
  • What industry is Cue Biopharma in?
  • What country is Cue Biopharma based in?
  • When did Cue Biopharma go public?
  • Is Cue Biopharma in the S&P 500?
  • Is Cue Biopharma in the NASDAQ 100?
  • Is Cue Biopharma in the Dow Jones?
  • When was Cue Biopharma's last earnings report?
  • When does Cue Biopharma report earnings?
  • Should I buy Cue Biopharma stock now?

What is the ticker symbol for Cue Biopharma?

The ticker symbol for Cue Biopharma is NASDAQ:CUE

Does Cue Biopharma pay dividends?

No, Cue Biopharma does not pay dividends

What sector is Cue Biopharma in?

Cue Biopharma is in the Healthcare sector

What industry is Cue Biopharma in?

Cue Biopharma is in the Biotechnology industry

What country is Cue Biopharma based in?

Cue Biopharma is headquartered in United States

When did Cue Biopharma go public?

Cue Biopharma's initial public offering (IPO) was on January 2, 2018

Is Cue Biopharma in the S&P 500?

No, Cue Biopharma is not included in the S&P 500 index

Is Cue Biopharma in the NASDAQ 100?

No, Cue Biopharma is not included in the NASDAQ 100 index

Is Cue Biopharma in the Dow Jones?

No, Cue Biopharma is not included in the Dow Jones index

When was Cue Biopharma's last earnings report?

Cue Biopharma's most recent earnings report was on Nov 14, 2024

When does Cue Biopharma report earnings?

The next expected earnings date for Cue Biopharma is Apr 8, 2025

Should I buy Cue Biopharma stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions